Position in CGON
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$30,862,892
+$8,825,820 QoQ
Shares Held
456,012
-14.1% QoQ
Ownership
0.517%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CGON Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $1,158,535,687 across 116 Biotechnology names. CGON ranks #9 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
215,165 | $96,079,779 | |
| 2 | INSM |
INSMED Inc
|
499,756 | $81,720,101 | |
| 3 | ABVX |
Abivax S.A.
|
631,838 | $70,355,161 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
836,552 | $62,122,351 | |
| 5 | ARGX |
Argenx SE
|
71,598 | $52,284,439 | |
| 6 | RPRX |
Royalty Pharma plc
|
932,650 | $44,739,220 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
582,318 | $39,673,325 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
717,253 | $35,260,157 |
All Filings in CGON
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,862,892 | 456,012 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $22,037,072 | 530,758 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $15,970,174 | 396,479 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,308,454 | 396,479 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,291,456 | 134,400 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,737,004 | 60,565 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,285,117 | 60,565 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,912,037 | 60,565 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||